Sutro Biopharma (STRO) Insider Trading & Ownership $3.96 -0.12 (-2.94%) (As of 11/13/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sutro Biopharma (NASDAQ:STRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$60,925.00 Get STRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Sutro Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address STRO Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth Sutro Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/29/2024Nicki VasquezInsiderSell12,185$5.00$60,925.00 (Data available from 1/1/2013 forward) STRO Insider Trading Activity - Frequently Asked Questions Who is on Sutro Biopharma's Insider Roster? The list of insiders at Sutro Biopharma includes Brunilda Shtylla, Nicki Vasquez, and William J Newell. Learn more on insiders at STRO. What percentage of Sutro Biopharma stock is owned by insiders? 5.90% of Sutro Biopharma stock is owned by insiders. Learn more on STRO's insider holdings. Which Sutro Biopharma insiders have been selling company stock? The following insiders have sold STRO shares in the last 24 months: Brunilda Shtylla ($125,969.55), and Nicki Vasquez ($60,925.00). How much insider selling is happening at Sutro Biopharma? Insiders have sold a total of 39,226 Sutro Biopharma shares in the last 24 months for a total of $186,894.55 sold. Sutro Biopharma Key ExecutivesMr. William J. Newell J.D. (Age 66)CEO & Director Compensation: $1.06MDr. Hans-Peter Gerber Ph.D. (Age 61)Chief Scientific Officer Compensation: $575.83kDr. Anne Elizabeth Borgman-Hagey M.D. (Age 56)Chief Medical Officer Compensation: $848.98kMs. Jane Chung R.Ph. (Age 53)President & COO Compensation: $934.64kDr. James R. Swartz DScPh.D., Sc.D., FounderMr. Edward C. Albini M.B.A (Age 66)CFO & Secretary Compensation: $596.4kDr. Venkatesh Srinivasan Ph.d. (Age 62)Chief Technical Operations Officer Mr. David Pauling J.D.M.A., General CounselMs. Linda A. Fitzpatrick (Age 67)Chief People & Communications Officer Compensation: $595.79kDr. Nicki Vasquez Ph.D. (Age 61)Chief Portfolio Strategy & Alliance Officer More Insider Trading Tools from MarketBeat Related Companies Gyre Therapeutics Insider Selling Praxis Precision Medicines Insider Selling Kura Oncology Insider Selling Cassava Sciences Insider Selling ANI Pharmaceuticals Insider Selling Arcutis Biotherapeutics Insider Selling Bicara Therapeutics Insider Selling Ardelyx Insider Selling Bicycle Therapeutics Insider Selling Applied Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:STRO) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sutro Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sutro Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
